TNF and acute respiratory distress syndrome: However, ibrutinib treatment markedly suppressed their levels (Figure 5A–H), implying that ibrutinib alleviates poly I:C- and LPS-induced ALI by suppressing IL-1β, TNF-α, and neutrophil aggregation levels.